Nutrition Research
Volume 26, Issue 12 , Pages 637-643 , December 2006

Simvastatin and supplementation with ω-3 polyunsaturated fatty acids and vitamins improves claudication distance in a randomized PILOT study in patients with peripheral vascular disease

  • Juan J. Carrero

      Affiliations

    • Department of Biochemistry and Molecular Biology, University of Granada, Granada 18071, Spain
    • Corresponding Author InformationCorresponding author. K56. Divisions of Renal Medicine and Baxter Novum, Karolinska University Hospital at Huddinge, 14186 Stockholm, Sweden. Tel.: +46 8 58583982; fax: +46 8 58583925.
    • ,
  • Eduardo López-Huertas

      Affiliations

    • Department of Nutrition and Health, Puleva Biotech SA, Granada 18004, Spain
    • ,
  • Luis M. Salmerón

      Affiliations

    • Service of Angiology and Vascular Surgery, University “San Cecilio” Hospital, Granada 18012, Spain
    • ,
  • Victoria E. Ramos

      Affiliations

    • Service of Angiology and Vascular Surgery, University “San Cecilio” Hospital, Granada 18012, Spain
    • ,
  • Luis Baró

      Affiliations

    • Department of Nutrition and Health, Puleva Biotech SA, Granada 18004, Spain
    • ,
  • Eduardo Ros

      Affiliations

    • Service of Angiology and Vascular Surgery, University “San Cecilio” Hospital, Granada 18012, Spain

Received 19 June 2005 ,Revised 21 August 2006 ,Accepted 26 September 2006.

References 

  1. Hirsch AT, Hiatt WR, PARTNERS Steering Committee . PAD awareness, risk, and treatment: new resources for survival—the USA PARTNERS program. Vasc Med. 2001;6:9–12
  2. Donnelly R, Yeung JMC. Management of intermittent claudication: the importance of secondary prevention. Eur J Vasc Endovasc Surg. 2002;23:100–107
  3. Leng GC, Fowkes FGR. The epidemiology of peripheral arterial disease. Vasc Med Rev. 1993;4:5–18
  4. Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann TJ, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992;326:381–386
  5. Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286:1317–1324
  6. Mukherjee D, Lingam P, Chetcuti S, Grossman PM, Moscucci M, Luciano AE, et al. Missed opportunities to treat atherosclerosis in patients undergoing peripheral vascular interventions: insights from the University of Michigan Peripheral Vascular Disease Quality Improvement Initiative (PVD-QI2). Circulation. 2002;106:1909–1912
  7. Cassar K, Coull R, Bachoo P, Macaulay E, Brittenden J. Management of secondary risk factors in patients with intermittent claudication. Eur J Vasc Endovasc Surg. 2003;26:262–266
  8. Norman PE, Eikelboom JW, Hankey GJ. Peripheral arterial disease: prognostic significance and prevention of atherothrombotic complications. Med J Aust. 2004;181:150–154
  9. McDermott MM, Guralnik JM, Greenland P, Pearce WH, Criqui MH, Liu K, et al. Statin use and leg functioning in patients with and without lower-extremity peripheral arterial disease. Circulation. 2003;107:757–761
  10. Sommerfield T, Hiatt WR. Omega-3 fatty acids for intermittent claudication. Cochrane Database Syst Rev. 2004;(3):CD003833
  11. Ramirez-Tortosa MC, Urbano G, Lopez-Jurado M, Nestares T, Gomez MC, Mir A, et al. Extra-virgin olive oil increases the resistance of LDL to oxidation more than refined olive oil in free-living men with peripheral vascular disease. J Nutr. 1999;129:2177–2183
  12. Aguilera CM, Mesa MD, Ramirez-Tortosa MC, Nestares MT, Ros E, Gil A. Sunflower oil does not protect against LDL oxidation as virgin olive oil does in patients with peripheral vascular disease. Clin Nutr. 2004;23:673–681
  13. Kleijnen J, Mackerras D. Vitamin E for intermittent claudication. Cochrane Database Syst Rev. 2000;(2):CD000987
  14. Robinson K, Arheart K, Refsum H, Brattstrom L, Boers G, Ueland P, et al. Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group. Circulation. 1998;97:437–443
  15. Wilmink AB, Welch AA, Quick CR, Burns PJ, Hubbard CS, Bradbury AW, et al. Dietary folate and vitamin B6 are independent predictors of peripheral arterial occlusive disease. J Vasc Surg. 2004;39:513–516
  16. Hooper L, Griffiths E, Abrahams B, Alexander W, Atkins S, Atkinson G, et al. Dietetic guidelines: diet in secondary prevention of cardiovascular disease (first update, June 2003). J Hum Nutr Diet. 2004;17:337–349
  17. Baro L, Fonolla J, Pena JL, Martinez-Ferez A, Lucena A, Jimenez J, et al. n-3 Fatty acids plus oleic acid and vitamin supplemented milk consumption reduces total and LDL cholesterol, homocysteine and levels of endothelial adhesion molecules in healthy humans. Clin Nutr. 2003;22:175–182
  18. Carrero JJ, Baro L, Fonolla J, Gonzalez-Santiago M, Martinez-Ferez A, Castillo R, et al. Cardiovascular effects of milk enriched with omega-3 polyunsaturated fatty acids, oleic acid, folic acid, and vitamins E and B6 in volunteers with mild hyperlipidemia. Nutrition. 2004;20:521–527
  19. Mataix J, Mañas M, Llopis J, Martinez-Victoria E. Tabla de composición de alimentos españoles. Granada (Spain): Universidad de Granada; 1998;
  20. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502
  21. Lepage G, Roy CC. Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res. 1986;27:114–120
  22. Araki A, Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr. 1987;422:43–52
  23. Tabet S, Berg AO, for the US Preventive Services task Force . Screening for peripheral arterial disease. In: Guide to clinical preventive services: report of the US Preventive Services Task Force. Baltimore, MD: Williams and Wilkins; 1996;p. 63–66
  24. Rader JI. Folic acid fortification, folate status and plasma homocysteine. J Nutr. 2002;132:2466–2470
  25. Lawson LD, Hughes BG. Absorption of eicosapentaenoic acid and docosahexaenoic acid from fish oil triacylglycerols or fish oil ethyl esters co-ingested with a high-fat meal. Biochem Biophys Res Commun. 1988;156:960–963
  26. Visioli F, Rise P, Plasmati E, Pazzucconi F, Sirtori CR, Galli C. Very low intakes of n-3 fatty acids incorporated into bovine milk reduce plasma triacylglycerols and increase HDL-cholesterol concentrations in healthy subjects. Pharmacol Res. 2000;41:571–576
  27. Third Report of the National Cholesterol Education Programme Expert Panel on “detection, evaluation and treatment of high blood cholesterol in adults (ATP III)”. 2002 National Institutes of Health (NIH), publication number 02-5215.
  28. Mason JC. Statins and their role in vascular protection. Clin Sci (Lond). 2003;105:251–266
  29. Mohler ER, Hiatt WR, Creager MA. Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease. Circulation. 2003;108(12):1481–1486
  30. Mondillo S, Ballo P, Barbati R, Guerrini F, Ammaturo T, Agricola E, et al. Effects of simvastatin on walking performance and symptoms of intermittent claudication in hypercholesterolemic patients with peripheral vascular disease. Am J Med. 2003;114(5):359–364
  31. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383–1389
  32. Aronow WS, Nayak D, Woodworth S, Ahn C. Effect of simvastatin versus placebo on treadmill exercise time until the onset of intermittent claudication in older patients with peripheral arterial disease at six months and at one year after treatment. Am J Cardiol. 2003;92:711–712
  33. Ernst E. Effects of n-3 fatty acids on blood rheology. J Intern Med Suppl. 1989;225:129–132
  34. Ho M, Maple C, Bancroft A, McLaren M, Belch JJ. The beneficial effects of omega-3 and omega-6 essential fatty acid supplementation on red blood cell rheology. Prostaglandins Leukot Essent Fatty Acids. 1999;61:13–17
  35. Vicaut E. Opposite effects of red blood cell aggregation on resistance to blood flow. J Cardiovasc Surg. 1995;36:361–368
  36. Thies F, Garry JM, Yaqoob P, Rerkasem K, Williams J, Shearman CP, et al. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet. 2003;361:477–485
  37. De Vriese AS, Blom HJ, Heil SG, Mortier S, Kluijtmans LA, Van de Voorde J, et al. Endothelium-derived hyperpolarizing factor–mediated renal vasodilatory response is impaired during acute and chronic hyperhomocysteinemia. Circulation. 2004;109:2331–2336
  38. Spark JI, Robinson JM, Gallavin L, Gough MJ, Homer-Vanniasinkam S, Kester RC, et al. Patients with chronic critical limb ischemia have reduced total antioxidant capacity and impaired nutritional status. Eur J Vasc Endovasc Surg. 2002;24:535–539

☆ This study was supported by a PhD educational grant from the University of Granada and by Puleva Biotech SA, Granada, Spain.

PII: S0271-5317(06)00240-5

doi: 10.1016/j.nutres.2006.09.024

Nutrition Research
Volume 26, Issue 12 , Pages 637-643 , December 2006

Article Tools